What You Ought to Know
- Healthcare outcomes intelligence chief PatientIQ has raised $30M in Sequence C financing led by Chicago-based healthcare non-public fairness agency Hughes & Company, with continued backing from Health Enterprise Partners and August Capital.
- Since finishing its Sequence B spherical in 2022, PatientIQ has scaled its EHR-integrated footprint from 200 to greater than 870 healthcare supplier organizations, overlaying over 17 million sufferers and capturing greater than 70 million affected person outcomes throughout 20+ medical specialties.
- Travis Hughes, Founder and Managing Companion of Hughes & Firm, joins PatientIQ’s Board of Administrators.
- Connects instantly through cloud integrations into greater than 50 digital well being document (EHR) platforms—together with Epic, Oracle Well being (Cerner), and athenahealth—to embed patient-reported consequence measures (PROMs) instantly into native scientific charting queues.
Scaling Automated Outcomes Seize Throughout 870 Well being Techniques
Since closing its Sequence B spherical in 2022, PatientIQ has expanded its enterprise footprint from 200 supplier organizations to greater than 870 healthcare methods, non-public practices, and specialty clinics. The platform now covers over 17 million sufferers nationwide and has collected greater than 70 million affected person outcomes throughout 20-plus medical specialties, together with orthopedics, neurosurgery, and thoracic surgical procedure.
PatientIQ embeds instantly into greater than 50 EHR platforms—together with Epic, Oracle Well being, and athenahealth—triggering validated survey assortment at standardized pre- and post-operative scientific intervals with out requiring clinicians to exit their major charting screens.
The brand new capital will fund three strategic initiatives:
- Specialty and Registry Deepening: Expands integration throughout massive well being methods whereas powering nationwide scientific knowledge registries for main specialty our bodies, together with the American Academy of Orthopaedic Surgeons (AAOS), the American Affiliation of Neurological Surgeons (AANS), and the Society of Thoracic Surgeons (STS).
- Life Sciences Actual-World Proof (RWE): Grows its analysis pipeline for medical system and biopharma producers—together with enterprise purchasers similar to Johnson & Johnson and Zimmer Biomet—to help post-market scientific follow-up (PMCF), FDA regulatory submissions, and longitudinal comparative effectiveness research.
- Direct-to-Affected person Commerce: Establishes a market layer designed to attach sufferers on to related rehabilitation instruments, specialty medical provides, and scientific restoration companies throughout their post-treatment care journeys.
